Cardiovascular Outcomes and Mortality in Vascular Surgical Patients
Sponsor
University of Cape Town (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05208957
Collaborator
(none)
400
18
Study Details
Study Description
Brief Summary
This is a registry-based study of elective vascular surgical patients undergoing intermediate or high-risk vascular surgical interventions at Groote Schuur hospital, a tertiary academic center, over a 12 month period.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
400 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Cardiovascular Outcomes and Mortality in Vascular Surgical Patients. A Registry-based Study of in Hospital Mortality and Postoperative Complications in Elective Vascular Surgery at Groote Schuur Hospital
Anticipated Study Start Date
:
Jun 1, 2022
Anticipated Primary Completion Date
:
Jun 1, 2023
Anticipated Study Completion Date
:
Dec 1, 2023
Outcome Measures
Primary Outcome Measures
- Determine in-hospital mortality in elective vascular surgical patients [12 months]
Secondary Outcome Measures
- Determine incidence of MACE in elective vascular surgical patients. [12 months]
- Describe the risk factors associated with MACE in elective vascular surgical patients [12 months]
- Determine incidence of post-operative complications in elective vascular surgical patients [12 months]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
All patients undergoing vascular surgery:
-
18 years and older
-
Elective procedures
-
Moderate- to high-risk surgical interventions
Exclusion Criteria:
-
Emergency vascular procedures
-
Low risk vascular surgery, i.e. venous stripping
-
All non-vascular surgical interventions
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Cape Town
Investigators
- Principal Investigator: Christella Alphonsus, MBChB, University of Cape Town
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Christella Alphonsus,
Study Principal investigator,
University of Cape Town
ClinicalTrials.gov Identifier:
NCT05208957
Other Study ID Numbers:
- HREC760/2021
First Posted:
Jan 26, 2022
Last Update Posted:
May 18, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No